image
image
  • Home
  • About us
  • Journals
  • Guidelines
    • Author Guidelines
    • Editor Guidelines
    • Reviewer Guidelines
  • Article Submission
  • Join as Editor
  • Join as Reviewer
  • contact
    • Login
    • Register
  • Login
  • Register

EC Diabetes and Metabolic Research

Current Issue

Editorial

Bergenin and Diabetes Mellitus: State of the Art

Carmine Finelli. 6(2): 01-04.

Research Article

Remission of Type 2 Diabetes, Decreased Inflammation and Cardiovascular Risk Factors in Obese Adults: Randomized Control Trial

Frankie B Stentz*, Damon Lawson, Sidney Tucker, John Christman and Chris Sands. 6(2): 35-51.

Research Article

Hypo-glycaemia and Associated Factors among Type 1 Diabetes Mellitus Patients Attending the Outpatient Clinics of DebreTabr Compressive and Specialized Hospital, South Gondar Zone, North West Ethiopia. A Cross-Sectional Study

Libsuye Yalgaw Zimamu (BSC), Gashaw Mekete Adal (MSc) and Gashaw Mehiret Wubet(MD). 6(2): 05-26.

Review Article

Icosema: Summary of the Emerging Data for Insulin Icodec and the Study Designs for the Novel GLP-1 Receptor Agonist/Basal Insulin Injection

Jessica Huston. 6(2): 01-04.

Review Article

Calciferols: Momentum of these Hormones

Alfredo F Jacome. 6(2): 05-14.

Mini Review

Adipocyte Nanobodies May Combat the Inheritable Obese Traits in the Foetus

Akanksha Awadhesh Singh. 6(2): 15-18.

Literature Review

Evaluation of Primary Health Care Service Implementation Focusing on Prevention and Treatment of Non Communicable Diseases in Yeka Subcity Addis Ababa, 2022

Tesfalem Geremew and Alemayew Terefa. 6(2): 19-34.

Journal Menu

  • Aim and Scope
  • Editorial Board
  • Articles in Press
  • Current Issue
  • Archive

Downloads

  • Cover Letter
  • Manuscript Template

Journal metrics

Publication Duration 28 Days
Acceptance rate 36%
Total Publications 1200
Editorial board members 149
Impact Factor 0.336
IC Value 4.78
Article Processing Fee 499 USD

PubMed Indexed Articles


EC Pharmacology and Toxicology

LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology

LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology

LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

Subscribe To Our Newsletter

ECronicon Journal

  • About
  • Privacy Policy
  • Contact Us
  • Publication Process

Our Services

  • Author Guidelines
  • Editor Guidelines
  • Reviewer Guidelines

Quick Links

  • Advertising
  • Reprints

Information

  • Phone +44 20 3769 9658
  • Email editor@ecronicon.uk
  • Address 32, 19-21 Crawford Street London W1H 1PJ United Kingdom

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.org

Colored Stripes